Stay updated on Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.4.2 is now shown on the page, replacing the previous Revision: v3.4.1.SummaryDifference0.0%

- Check15 days agoChange DetectedRevision: v3.4.1 has been added, and the funding-lapse notice regarding government status has been removed.SummaryDifference0.1%

- Check22 days agoChange DetectedA site-wide notice about a lapse in government funding and that the NIH Clinical Center is open has been added, with a link to opm.gov for status updates.SummaryDifference0.1%

- Check29 days agoChange DetectedAdded a 'Show glossary' option and updated footer metadata to 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page's revision indicator updated to Revision: v3.3.4, replacing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedAdded a consolidated 'Locations' section with numerous regional entries (e.g., Alabama, Arizona, California, etc., plus Australia and European regions) and removed the separate 'X Locations' subsections.SummaryDifference1%

Stay in the know with updates to Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page.